New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
09:13 EDTAAL, COH, CELG, KKR, LXRX, GRMN, SDRL, SLXP, MSM, SIMG, AVAV, BOBE, LO, RAI, GIMO, TCS, BPOn The Fly: Pre-market Movers
HIGHER: American Airlines (AAL), up 5.5% after reporting its June traffic rose 1%, forecasting its 2014 total system capacity to be up 3% from last year... AeroVironment (AVAV), up 5.5% after reporting better than expected Q4 earnings results... Reynolds American (RAI), up 1.3% after Daily Mail reported that British American Tobacco (BTI) is rumored to be near a deal to buy out the stake in Reynolds it does not already own, which would prevent a Reynolds takeover of Lorillard (LO). Lorillard shares are down 1.4% in pre-market trade following the report... Lexicon (LXRX), up 11.5% after announcing JDRF, the world's largest non-profit supporter of type 1 diabetes research, will provide funding to support a Phase 2 trial to evaluate the efficacy and safety of LX4211... Seadrill (SDRL), up 3% after cancelling contemplated convertible bond issuance... KKR (KKR), up 1.3% after upgraded to Outperform at Credit Suisse. DOWN AFTER EARNINGS: Container Store (TCS), down 15%... Bob Evans (BOBE), down 1.2%... MSC Industrial (MSM), down 3%. ALSO LOWER: Gigamon (GIMO), down 32% following downgrades at five firms after the company lowered its Q2 revenue guidance... Garmin (GRMN), down 2.7% following downgrade at Pacific Crest... Silicon Image (SIMG), down 11% after cutting second quarter guidance... Salix (SLXP), down 4% after announcing deal to combine with Cosmo Technologies... Celgene (CELG), down 1.5% after OTEZLA did not achieve primary endpoint in Phase III trial... Coach (COH), down 0.7% following downgrade at Buckingham... BP (BP), down 1% after downgraded at Deutsche Bank.
News For AAL;TCS;GIMO;RAI;LO;BOBE;AVAV;SIMG;MSM;SLXP;SDRL;GRMN;LXRX;KKR;CELG;COH;BP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 16, 2014
07:57 EDTAALAmerican Airlines volatility elevated into Q3 results
Subscribe for More Information
06:39 EDTKKRKKR announces minority investment in arago AG
Subscribe for More Information
05:23 EDTSDRLSeadrill downgraded to Reduce from Neutral at Nomura
Subscribe for More Information
October 15, 2014
12:46 EDTAALAirline stocks down following report that second ebola patient traveled on plane
The CDC announced earlier that a second health care worker who has been diagnosed with the Ebola virus traveled by air on October 13, a day before she reported symptoms. The CDC is reaching out to passengers who flew on Frontier Airlines flight 1143 Cleveland to Dallas/Fort Worth due to the proximity in time between the evening flight and first report of illness the following morning. Publicly traded companies in the space are trading lower following the report, including American Airlines (AAL) down 3.65% to $30.35, Delta Air Lines (DAL) down 4.39% to $31.37, JetBlue (JBLU) down 2.69% to $9.95, Southwest (LUV) down 2.5% to $29.24, and United Continental (UAL) down 5.5% to $40.66. Reference Link
07:44 EDTBPExxon, Shell behind rivals in lowering greenhouse gas emissions, WSJ reports
Subscribe for More Information
07:09 EDTSDRLSeadrill initiated with a Buy at ISI Group
Subscribe for More Information
October 14, 2014
13:09 EDTKKRGlaxoSmithKline seeks binding bids for mature drugs, Reuters reports
Subscribe for More Information
October 13, 2014
06:36 EDTBPSaudi Arabia content to let oil prices stay low, Reuters reports
Subscribe for More Information
October 12, 2014
13:53 EDTBPKuwaiti Minister says OPEC unlikely to cut production, WSJ says
Subscribe for More Information
13:45 EDTBPSaudis take aggressive oil measures in Europe, WSJ says
Subscribe for More Information
October 10, 2014
16:06 EDTBOBEBob Evans says Steven Davis remains CEO, director
Subscribe for More Information
15:42 EDTAALPlane held on Las Vegas tarmac over Ebola scare, Reuters reports
Subscribe for More Information
11:40 EDTAALStocks with call strike movement; HTZ AAL
Subscribe for More Information
09:05 EDTBPBP begins $1.1B North Sea project, Bloomberg says
BP CEO Bob Dudley said that the company is poised to begin a project worth close to $1.1B in the North Sea this month, which is anticipated to supply oil and gas into the next ten years, according to Bloomberg, citing comments from Dudley. Reference Link
08:41 EDTCELGCelgene reports apremilast significantly improved preexisting psoriasis in study
Subscribe for More Information
08:39 EDTCELGCelgene says data show Apremilast treatment resulted in improved quality of life
Subscribe for More Information
06:48 EDTLO, RAISenators call on FDA to adopt strict e-cigarette warning
Subscribe for More Information
October 9, 2014
11:14 EDTSLXPAllergan raises outlook again as Valeant pursuit continues
Drug maker Allergan (AGN) this morning preannounced stronger than expected results and again raised its fiscal year profit guidance. The beat and raise results come after The Wall Street Journal reported on Tuesday that drug maker Valeant (VRX) and hedge fund Pershing Square intend to raise their previous bid for Allergan by $15 per share to about $191. Meanwhile, also on Tuesday, Reuters said that drug maker Actavis (ACT) plans to make a new merger offer to Allergan, and sources indicated to the news service that Allergan may be willing to consider an offer from Actavis if the bid is for more than $200 per share. WHAT'S NEW: Allergan estimated that its third quarter earnings per share would come in at $1.76-$1.78, versus analysts' consensus estimate of $1.48. The drug maker had previously provided Q3 EPS guidance of $1.44-$1.47. Allergan raised its fiscal 2014 EPS guidance to $6.20-$6.25 from $5.74-$5.80. Analysts' consensus estimate was $5.81. This is the fourth time that Allergan has raised its guidance this year. Allergan said that its markets have been strong around the world, while it is gaining market share in most categories. ANALYST REACTION: In a note to investors today, Wells Fargo analyst Larry Biegelsen wrote that, in the wake of Allergan's guidance increase, the company's price to earnings multiple could expand to 22x its estimated 2016 earnings, up from its current multiple of 19x. In addition to the raised guidance, a potential accretive acquisition by Allergan and the possibility that it will be acquired make such an increase in the multiple "quite possible," Biegelsen contended. He kept an Outperform rating on the stock. WHAT'S NOTABLE: Allergan has reportedly held advanced talks about acquiring another company in the sector, Salix (SLXP), although CNBC's David Faber on October 2 reported that the talks between the two companies about a merger had "cooled considerably." PRICE ACTION: In late morning trading, Allergan rose fractionally to $191.06 while Valeant slid 1.5% to $124.08.
09:41 EDTCOHBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
08:50 EDTSLXPAllergan shares have further upside, says Wells Fargo
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use